Resources


Advanced



 Quick Order
  This area of the site
   requires the
  Acrobat Reader
  and the ability to
  view zipped files.
  Click below to
  download the
   necessary
   software.
  The StuffIt
   software can be
   used for either
   Windows or
   Macintosh.


Download the Adobe Acrobat reader

Download the StuffIt Expander

Download WinZip

 
 
Slide Lecture Programs
2006 Core Curriculum
Antiplatelet Interventions in ACS
March 10, 2006

III:  ACC/AHA UA/NSTEMI Guidelines: Role of GP IIb/IIIa Inhibitors" width="220" height="147" border="0">

ACC/AHA UA/NSTEMI Guidelines: Role of GP IIb/IIIa Inhibitors
 
 
28
  Slide: 28 - ACC/AHA guidelines for UA/NSTEMI: GP IIb/IIIa inhibitors</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

ACC/AHA guidelines for UA/NSTEMI: GP IIb/IIIa inhibitors
 
 
29
  Slide: 29 - ACC/AHA UA/NSTEMI Guidelines: Management of high-risk patients</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

ACC/AHA UA/NSTEMI Guidelines: Management of high-risk patients
 
 
30
  Slide: 30 - Mortality risk is lower with early (<24-hour) GP IIb/IIIa inhibition</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Mortality risk is lower with early (<24-hour) GP IIb/IIIa inhibition
 
 
31
  Slide: 31 - Recommended therapies for UA/NSTEMI</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Recommended therapies for UA/NSTEMI
 
 
32
  Slide: 32 - Majority of ACS patients undergo catheterization</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Majority of ACS patients undergo catheterization
 
 
<< previous      next >>

Home | Literature Update | Journal Link | Resources | Meeting Highlights | Members | About VBWG | Web Links